美國氣象預報機構CPC：厄爾尼諾現象正在增強，2026年北半球秋季和冬季出現超強厄爾尼諾事件的概率超過90%。

German 10-year bond yield continued to rise, up 4bps on the day to 3.48%.

Novo Nordisk (NVO.N) said its long-acting growth hormone injection, marketed in China as NuozeYou, received approval for three additional pediatric indications: growth retardation associated with Noonan syndrome in children aged 2.5 years and older; idiopathic short stature in children aged 2.5 years and older; and children born small for gestational age who remain short at age 2, for treatment in patients aged 2.5 years and older. The product was previously approved in China for pediatric growth hormone deficiency.